Lewy Body Dementia: An Underdiagnosed Degenerative Brain Disease
1.66 Contact Hours
Written by: Karen Truman, PhD
To successfully complete this course and receive your certificate, you must read the content online or in the downloadable PDF, pass the post test with a 70% or better, and complete the evaluation form by January 25, 2021.
You will only be asked to pay for the course if you decide to grade the post examination to earn a certificate with contact hours.
Corexcel is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation (ANCC).
This activity was developed by Corexcel without support from any commercial interest.
It is Corexcel's policy to ensure fair balance, independence, objectivity, and scientific rigor in all programming. In compliance with the American Nurses Credentialing Center (ANCC) we require that faculty disclose all financial relationships with commercial interests over the past 12 months.
No planning committee member has indicated a relevant financial relationship with a commercial interest involved with the content contained in this course.
Corexcel's provider status through ANCC is limited to educational activities. Neither Corexcel nor the ANCC endorse commercial products.
After completing this Lewy Body Dementia course participants should be able to:
- Identify the characteristics of Lewy Body Disease.
- List medications that can cause unintended consequences.
- Describe several examples of treatment modalities.
- Apply preventative techniques for risk reduction.
- Identify community, medical and other resources.
This course is designed for all medical professionals who come in contact with persons who have been diagnosed with a form of dementia and may have difficult behavior. These patients may be seen at home with a caregiver, in doctors' offices, hospitals, mental health settings, long-term care communities, or other settings.
Friedrich Heinrich Lewy
Dr. Lewy was a prominent German-born American neurologist. In 1912, Friedrich Heinrich Lewy first described these inclusion bodies named after him. He is best known for the discovery of the protein masses in brain biopsy samples, which are a characteristic indicator of Parkinson's disease and dementia with Lewy bodies.
The second most common form of dementia is Lewy Body. It is also called Lewy Body Dementia (LBD), Diffuse Lewy Body Disease, Lewy Body Disease, Senile Dementia of Lewy Type, Cortical Lewy Body Disease, Lewy Body Variant of Alzheimer's Disease or Parkinson's Disease Dementia. It is currently widely underdiagnosed and yet affects an estimated 1.3 million people (considerably more men than women) just in the United States. LBD usually occurs sporadically, in people with no known family history of the disease. About 20% of persons with a dementia have Lewy Body Dementia. This is a progressive degenerative disease of the brain. It shares characteristics and clinically recognizable features with several other diseases, especially Alzheimer's and Parkinson's.
There are two types of LBD:
- Dementia with Lewy Bodies
- Parkinson's Disease Dementia
The earliest signs of these two diseases differ but reflect the same biological changes in the brain. Over time, people with dementia with Lewy bodies or Parkinson's disease dementia may develop similar symptoms. LBD patients will benefit from regularly scheduled visits with a neurologist who specializes in dementia and/or movement disorders. Memory disorder and movement disorder clinics are found all over the world. They are usually associated with a medical university or large hospital systems.